Kolexia
Amsallem Daniel
Pédiatrie
Hôpital Jean-Minjoz
Besançon, France
53 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Troubles du langage Déficience intellectuelle Syndrome de Rett Microcéphalie Encéphalopathies Prédisposition génétique à une maladie Dyskinésies Maladies chromosomiques Ataxie

Industries

UCB
5 collaboration(s)
Dernière en 2023
Sanofi
1 collaboration(s)
Dernière en 2020
Biocodex
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

IDAR: Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-myelin Oligodendrocytes Glycoprotein (Anti-MOG) Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial
Essai Clinique (Assistance publique – Hôpitaux de Paris)   22 novembre 2023
Impact of pharmacist medication review for paediatric patients: an observational study.
The International journal of pharmacy practice   08 novembre 2022
CHU de Besançon - Canicule : Dr Daniel Amsallem, chef du...
Facebook   17 juin 2022
The Largest Germline Heterozygous Deletion Encompassing Potocki-Shaffer and WAGR Syndromes Loci to Date: A Case Report.
Neuropediatrics   08 décembre 2021
The GRIA3 c.2477G > A Variant Causes an Exaggerated Startle Reflex, Chorea, and Multifocal Myoclonus.
Movement disorders : official journal of the Movement Disorder Society   05 mai 2020
Low penetrance in RANBP2-related autosomal dominant acute necrotizing encephalopathy (ADANE)
Abstracts from the 51st European Society of Human Genetics (ESHG) Conference, in conjunction with the European Meeting on Psychosocial Aspects of Genetics (EMPAG)   01 juillet 2019
Myelin oligodendrocyte glycoprotein antibodies spectrum disorder: clinical features and prognostic factors in a cohort of 150 adult patients
Multiple sclerosis (Houndmills, Basingstoke, England) Congress 2017   24 octobre 2017
Myelin oligodendrocyte glycoprotein antibodies predict a favourable outcome in neuromyelitis optica related disorders
Multiple sclerosis (Houndmills, Basingstoke, England) Congress 2017   24 octobre 2017
Diagnostic approach to neurotransmitter monoamine disorders: experience from clinical, biochemical, and genetic profiles.
Journal of inherited metabolic disease   18 septembre 2017
Type 3 Gaucher disease, diagnostic in adulthood.
Molecular genetics and metabolism reports   11 juillet 2017